| GTO ID | GTC1952 |
| Trial ID | NCT03634683 |
| Disease | Recurrent Hepatocellular Carcinoma |
| Altered gene | HBV gene |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | LioCyx |
| HLA | HLA class I |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | A Phase I/II, Open Label, Single Arm, Multicenter Study of LioCyx in Subjects With Recurrent Hepatitis B Virus-Related Hepatocellular Carcinoma Post Liver Transplantation |
| Year | 2018 |
| Country | China|Singapore |
| Company sponsor | Lion TCR Pte. Ltd. |
| Other ID(s) | LTCR-HCC-001 |
| Cohort 1 | |||||||||
|
|||||||||